Evelo Biosciences is reinventing the world of immune-therapeutics by harnessing the power of benign bacteria types as medicinal delivery vectors, primarily via the gut. They asked us to create a biomedical and scientific animation that would appeal to investors and the general public alike, and explain how these beneficial bacteria interact with cells in the gut to deliver medicines.